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 It has been reported that oxygen radicals are involved in the 
development of tissue injury in hypertension. To prevent 
oxidative stress, there are antioxidant systems inside the 
cells such as superoxide dismutase (SOD), glutathione 
peroxidase (GPX), glutathione reducatase (GR), catalase 
(CAT) and glutathione S-transferase (GST). In this study 
changes in these antioxidant activities were estimated in the 
outer wall of the left ventricles from spontaneously 
hypertensive rats (SHR), stroke prone SHR (SHRSP) and 
normal Wister Kyoto rats (WKY). The activities of 
manganese-superoxide dismutase (Mn-SOD), which local-
izes in mitochondria and GST were lower in the left ventricles 
of SHR and SHRSP compared to those in WKY. Slight 
decrease in the GPX activity was observed in the left ventri-
cles from SHR and SHRSP. On the other hand, the activity of 
GR and catalase was not different in them. The effect of 
Nicardipine, a calcium channel blocker, on these antioxidant 
activities was also esimated. Treatment of these rats with 
nicardipine (150 mg/kg/day) for 4 weeks improved blood 
pressure, from 176±10 mmHg to 140±8 mmHg in SHR (n = 
5), from 201±11 mmHg to 167±5 in SHRSP (n = 5), respec-
tively, and restored the activities of Mn-SOD, GST and GPX. 
Collectively, these results suggest that oxidative stress in 
hypertensive rat heart causes supression of antioxidant 
activities, which may contribute to myocardical injury, and 
nicardipine plays a cardioprotective role to reduce the 
oxidative stress in hypertensive heart.
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Introduction 
 It has been reported that oxygen radicals play a critical 
role in the pathogenesis of hypertension (1). Cardiac 
hypertrophy, a major underlying cause of heart disorders
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such as myocardial infarction and cardiac arrythmya (2) 
is formed when increased external stimuli such ae 
hemodynamic overload and neurohumoral factors are 
continuoursly imposed on cardiac myocardium (3-6). 
These findings were affirmed by studies on hypertension 
using animal models having shown that hypertension 
linked to anatomical alterations and endothelial dysfunc-
tion in heart to lead to myocardial hypertrophy (3). 
 In hypertension, hemodynamic overload can induce 
myocardial hypertrophy. Cardiac hypertrophy is associ-
ated with myocardial ischemia due to disturbances in 
coronary physiology (1). Under this condition oxygen 
radicals are produced by xanthine oxidase (XO) in the 
endothelium (6-9). In addition to the hemodynamic over-
load, the roles of oxygen radicals have been emphasized in 
the progression of vascular injury in hypertension (10). 
 To scavenge oxidants, there are defense systems inside 
the cells. Superoxide dismutase (SOD) scavenges 
superoxide to form H2O2. There are two isozymes of SOD 
inside the cell. Cu, Zn-SOD presents in cytosol and Mn-
SOD in mitochondria. These two isozymes are believed to 
detoxify superoxide in a similar manner. Especially, when 
mitochondrial respiratory chains leak a large amount of 
superoxide anion radicals which chain react with mem-
brane phospholipid to develop lipid peroxidation; Mn-SOD 
can be induced and catalyzes superoxide detoxification 
within mitochondria. H202, which is formed by the cata-
lytic reaction of SOD from H2O and superoxide, is far 
more toxic than superoxide and can permiate cell mem-
branes. It is detoxified by glutathione peroxidase (GPX) 
or catalase. GPX uses glutathione as a substrate. 
Glutathione reductase (GR) converts oxidized glutathione 
by GPX to reduced glutathione and NADPH to NADP. 
GPX and GR are important in the redox cycle of NADP/ 
NADPH. Glutathione S-transferase detoxifies xenobiotics 
to form glutathione S-conjugates. 
 Changes in the activities of antioxidants have been 
reported in SHR heart (11-13) or kidney (14). However, 
the data were not consistent nor contributable to under-
stand the pathological significance of antioxidants in
hypertension. Furthermore, the regulation of them in 
hypertensive tissues in response to oxidative stress is not 
clear. In the present study, the activity of SOD and GSH 
related enzymes was estimated in the outer wall of the left 
ventricles from spontaneously hypertensive rat (SHR), 
stroke prone SHR (SHRSP) and Wister Kyoto rat (WKY) 
hearts. In addition, the effect of nicardipine, a Ca" 




 Nicardipine was purchased from Yamanouchi Pharma-
ceutical Co., Tokyo, Japan. Glutathione reductase was 
from Pharmacia Fine Chemicals (Uppsala, Sweden). 
Animals and blood pressure measurements
 Six week old, male WKY, SHR, SHR of the Izumo colony 
(WKY/Izm, SHR/Izm, SHRSP/Izm) were obtained from 
the Disease Model Cooperative Research Association, 
Kyoto, Japan. A group of 2 to 3 rats was housed in a cage 
in an air-conditioned room at 24±1°C , humidity of 65±5 
%, with lights on 12 hours per day (7:00 a.m.-7:00 p. m.) 
at the Laboratory Animal Center for Biomedical Research 
Center, Nagasaki University School of Medicine. 10 of each 
group were divided into two group. Five rats of each group 
were fed with the diet containing nicardipine in a dose of 
0.1% (wt/wt) (27), for 4 weeks (from 8 to 12 weeks of 
age). Another 5 rats of each group was given the diet with 
no drug served as controls. Systolic blood pressure was 
measures indirectly using an electrosphy gmomanometer 
(PS-2000, Riken Kaihatsu, Tokyo) after prewarming the 
whole body for 10 min at 38 °C to dilate the caudal tail 
artery. 
 One day after measuring systolic blood pressure in the 
12 weeks-old animals, the rats were anesthetized with 
pentobarbital sodium (50 mg/kg body weight IP). The 
hearts were excised and washed with ice-cold isotonic 
solution (physiologic saline solution) and the outrer wall 
of the left ventricles was separated and divided in two 
pieces, one for protein and GSH assay, and another for 
gene expression. 
Enzyme Assay 
 After homogenization of the excited left ventricles in 5 
vol of ice-cold phophate buffered saline (0.9 vol of 0.154 
NaCI and 9 vol of 0.1 M NaH2PO4/Na2HPO4, pH 7.4) in a 
Polytron homogenizer (KINEMATICA), the homogenate 
was centrifugated at 13,000x g for 10 min. The super-
natant was stored at -80'C before use. The activity of
SOD was estimated according to the method described by 
McCord and Fridovich (McCord and Fridovich. 1969). The 
activity of catalase, GST, GPX and GR was estimated 
photometrically according to the method described by 
Beutler (Beutler, 1986). 1-Chloro-2,4-dinitrobenzene and 
glutathione (GSH) were used as substrate for GST and 
changes in the absorbance at 412 nm was esimated. GSH 
and NADPH were used for the estimation of GPX activity, 
and the decreasing of NADPH was monitored at 340 nm. 
Glutathione disulfide and NADPH were used for the 
estimation of GR activity and decreasing of NADPH was 
monitered. Hydrogen peroxide was used for the estimation 
of catalase activity and change in the absorbance at 240 
nm was estimated. One unit of enzyme activity was 
expressed as 1,a mol substrate changed/min. The total SOD 
activity was estimated by the cytochrome c reduction 
inhibition assay. The amounts of SOD required to inhibit 
the rate of reduction by 50% was defined as one unit of 
activity. The Mn-SOD which activity was obtained by 
substracting Cu, Zn-SOD activity is abolished by KCN 
from the total SOD activity. 
Statistical analysis 
 The data are given as the mean --LSD. Differences were 
calculated with Student's t-test.
Results 
Changes in the blood pressure and heart weight 
 Table 1 shows characteristics of the blood pressure, body 
weight and heart weight in hypertensive rats. The blood 
pressure was significantly more elevated in SHR (n = 5) 
than WKY (n = 5) (178 ± 11.8 mmHg vs 115 ± 3.5 mmHg, 
mean±SD, p<0.05). SHRSP rats were more severe (219 
± 12.9 mmHg). Ratio of heart weight/body weight (mg/ 
g) increased in SHR (5.25±0.01) and SHRSP (5.31±0.01) 
compared to that in WKY (4.04±0.03). 
Effect of nicardipine on the blood pressure and heart 
weight 
 Treatment was administrated for 4 weeks and the effect 
of nicardipine on the blood pressure and heart weight was 
estimated. Nicardipine had no apparent effect on the blood 
pressure, body and heart weight in WKY rats. It improved 
the levels of blood pressure of SHR from 176 ± 9.6 mmHg 
to 140±7.9 mmHg (p<0.05) and those of SHRSP from 
201±10.8 mmHg to 167±4.5 mmHg (p<0.05). Nicardipine 
also decreased the herat weight/body weight ratio in SHR 
(5.12±0.02 vs 5.25±0.01, p<0.05), SHRSP (5.02±0.01 vs 
5.31±0.01, p<0.05), respectively.
Table 1. Effect of nicardipine on body weight, blood pressure, and heart weight in hypertensive rats.
                          Body weight Systolic Heart weight Heart weight/Body weight    R
at Status (g) blood pressure (mg) (m / ) 
                                       (mmhg) g g 
                                          before after 
  WKY control(5) 240.0± 7.5 115± 3.5 114±6.5 970±3.3 4.04±0.03 
          nicardipine(5) 234.4± 5.4 123±10.9 116±8.2 946±2.4 4.03±0.01 
   SHR control(5) 177.8± 5.7 178±11.8* 169±5.5 934±3.2* 5.25±0.01 
          nicardipine(5) 175.6± 4.4 176± 9.6 140±7.9** 900±2.2** 5.12±0.02** 
 SHR-SP control(5) 178.8±11.8 219±12.9* 223±8.4 950±6.4* 5.31±0.01 
          nicardipine(5) 179.4±10.3 201±10.8 167±4.5** 900±5.1** 5.02±0.01** 
Rats were treated with nicardipine (150mg/kg/day) for four weeks. 
The numbers in parentheses indicate the numbers of animals in each group. 
*
, P<0.05 vs WKY 
**
, P<0.05 vs control of each group. Values are expressed as the mean ± SD.
Antioxidant activity 
 Change in the activity of antioxidants was estimated in 
the left ventricles. Decrease in the activity of Mn-SOD was 
observed in SHR compared to that in WKY (60.5 ± 1.9 
mU/mg protein vs 71.1 ± 3.2, p<0.05) . The decrease in 
Mn-SOD activity was more in SHRSP (51.9 ± 2.4 mU/mg 
protein) (Fig. 1). The activity of GST also decreased in 
SHR (26.9 ± 0.9 mU/mg protein) and more in SHRSP
(22.3±3.1 mU/mg protein) compared to that in WKY (3 
1.9 ± 1.O mU/mg protein) (Fig. 2). The activity of GPX 
was slighty reduced in SHR and SHRSP, although being 
not significant (Fig. 3). The activity of other antioxidants 
such as Cu, Zn-SOD (Fig. 4), catalase (Fig. 5) and GR 
(Fig. 6) was not different in these groups.
Figure 1. The activity of Mn-SOD in the left ventricle of rat 
hearts. The activity of Mn-SOD was estimated in the outer 
wall of left ventricles from rat hearts with or without the 
treatment with nicardipine for four weeks. The homogenized 
tissue was centrifugated and the supernatant was used as 
material for the estiamation of enzyme activities. The 
Mn-SOD activity was measured as described in Materials and 
Methods. Values are mean±SD of five samples. Lanes 1 and 
2, WKY ; lanes 3 and 4, SHR ; lanes 5 and 6, SHRSP. Lanes 2, 
4 and 6, treatment with nicardipine (150 mg/kg/day).
Figure 2. The activity of GST. The activity of GST was 
estimated in the outer wall of left ventricles from rat hearts 
with or without the treatment with nicardipine for four 
weeks. The GST activity was measured as described in 
Materials and Methods. Values are mean±SD of five sam-
ples. Lanes 1 and 2, WKY ; lanes 3 and 4, SHR ; lanes 5 and 6, 
SHRSP. Lanes 2, 4 and 6, treatment with nicardipine (150 
mg/kg/day).
Figure 3. The activity of GPX. The activity of GPX was 
estimated in the outer wall of left ventricles from rat hearts 
with or without the treatment with nicardipine for four 
weeks. The GPX activity was measured as described in 
Materials and Methods. Values are mean t SD of five sam-
ples. Lanes 1 and 2, WKY ; lanes 3 and 4, SHR ; lanes 5 and 6, 
SHRSP. Lanes 2, 4 and 6, treatment with nicardipine (150 
mg/kg/day).
Figure 5. The activity of catalase. The activity of catalase 
was estimated in the outer wall of left ventricles from rat 
hearts with or without the treatment with nicardipine for 
four weeks. The catalase activity was measured as described 
in Materials and Methods. Values are mean ± SD of five 
samples. Lanes 1 and 2, WKY ; lanes 3 and 4, SHR ; lanes 5 
and 6, SHRSP. Lanes 2, 4 and 6, treatment with nicardipine 
(150 mg/kg/day).
Figure 4. The activity of Cu,Zn-SOD. The activity of Cu,Zn-
SOD was estimated in the outer wall of left ventricles from 
rat hearts with or without the treatment with nicardipine for 
four weeks. The Cu,Zn-SOD activity was measured as de-
scribed in Materials and Methods. Values are mean t SD of 
five samples. Lanes 1 and 2, WKY ; lanes 3 and 4, SHR; lanes 
5 and 6, SHRSP. Lanes 2, 4 and 6, treatment with nicardipine 
(150 mg/kg/day).
Figure 6. The activity of GR.The activity of GR was esti-
mated in the outer wall of left ventricles from rat hearts with 
or without the treatment with nicardipine for four weeks. The 
GR activity was measured as described in Materials and 
Methods. Values are mean±SD of five samples. Lanes 1 and 
2, WKY ; lanes 3 and 4, SHR ; lanes 5 and 6, SHRSP. Lanes 2, 
4 and 6, treatment with nicardipine (150 mg/kg/day).
Discussion 
 Production of reactine oxygen species in SHR has been 
reported in microvascular walls (15, 16). Cardiomyocite 
hypertrophy in hypertension can be induced by oxidative 
stress, hemodynamic overload, and neurohumoral factors. 
These external stimuli are generally transduced into the 
cells through intracellular signal transduction cascade 
(17). 
 Supression of Mn-SOD activity together with an in-
crease in mitochondrial lipid peroxidation was first 
reported by Ohtsuki in SHR kidney (18). This suggests 
that mitochondrial damage and superoxide leak are 
present in hypertensive tissues. In the present study, the 
activity of Mn-SOD but not Cu, Zn-SOD decreased in SHR 
hearts and more in SHRSP hearts. The data are in good 
agreement with the previous report (18) and suggest that 
the impairment of mitochondrial function in hypertensive 
hearts. Mn-SOD is responsive to oxidative stress. The 
expression of Mn-SOD is stimulated in respons to oxida-
tive stress and cytokines (19). Whereas, the expression of 
Cu, Zn-SOD is not responsive to any stimulation, except 
for glycation of Cu, Zn-SOD protein in diabetic conditions 
(20). The supression of Mn-SOD activity observed in 
hypertensive hearts may be caused by oxidative stress in 
hypertension. A possible explanation for an increase in 
oxidative stress is a high activity of xanthine oxidase in 
hypertension. Miyamoto has reported that vasorelaxation 
can be induced by the treatemnt with xanthine oxidase 
inhibitors (9), which improve endothelial vasodilator 
function mediated by nitric oxide (8). 
 Intracellular GPX is a selenium-containing enzyme and 
its activity is stable under physiological and pathological 
conditions (21, 22). The regulation of GPX is not clear, 
however, decrease in the GPX activity in hypertensive 
hearts may reflect the oxidative stress in hypertension. 
Cardioprotective effect of nicardipine inhibition of the 
inward transport of calcium by nicardipine induces 
cardioprotective effect. It prevents mitochondrial calcium 
overload and concequently preserve the structure and 
function of myocardial cells while protecting against the 
deleterious effects of hypoxia and ischemia (23). 
Nicardipine calcium bockers also restore the impaired 
basoreceptor reflex control (24). In addition, the effect of 
nicardipine on coronary hemodynamics and myocardial 
oxygen consumption contributes to a cardioprotective 
effect. Decrease in the lipid peroxidation by nicardipine 
has been reported, suggesting the antioxidant activity of 
calcium blockers (25, 26). 
 In the present study, the activity of Mn-SOD, GPX and 
GST was normalized by the treatment with nicardipine. 
Although the regulation of the activity of these enzymes 
was not studied, the expression of genes encoding these 
enzymes may be regulated by similar transcription fac-
tors, which are stimulated when myocardial cells are
exposed to oxidative stress and can function to 
downregulate the expression of these antioxidant enzymes.
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